Author: Kumari G. Lokugamage; Adam Hage; Craig Schindewolf; Ricardo Rajsbaum; Vineet D. Menachery
Title: SARS-CoV-2 is sensitive to type I interferon pretreatment Document date: 2020_3_9
ID: 2w0zr9c0_32
Snippet: Considering the sensitivity to IFN-I, we next sought to evaluate changes between SARS-CoV 148 and SARS-CoV-2 viral proteins. Previous work has established several key IFN antagonist in 149 the SARS-CoV genome including NSP1, NSP3, ORF3b, ORF6, and others (26). Therefore, we 150 . CC-BY-NC 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi......
Document: Considering the sensitivity to IFN-I, we next sought to evaluate changes between SARS-CoV 148 and SARS-CoV-2 viral proteins. Previous work has established several key IFN antagonist in 149 the SARS-CoV genome including NSP1, NSP3, ORF3b, ORF6, and others (26). Therefore, we 150 . CC-BY-NC 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.07.982264 doi: bioRxiv preprint compared the sequence homology across viral proteins from SARS-CoV, SARS-CoV-2, and 151 several bat SARS-like viruses including WIV16-CoV (27), SHC014-CoV (28), and HKU3.1-CoV 152 (29). Using sequence analysis, we found several changes to SARS-CoV-2 that potentially 153 contribute to its type I IFN sensitivity (Fig. 4) . ORF3b, all five surveyed group 2B CoVs maintain ORF6; however, SARS-CoV-2 had only 69% 171 homology with SARS-CoV while the other three group 2B bat CoVs had >90% conservation. 172
Search related documents:
Co phrase search for related documents- IFN antagonist and SARS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- IFN antagonist and SARS cov genome: 1
- IFN antagonist and viral protein: 1, 2, 3, 4, 5, 6
- IFN sensitivity and SARS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- IFN sensitivity and SARS cov genome: 1, 2
- IFN sensitivity and SARS viral protein: 1
- IFN sensitivity and sequence analysis: 1, 2
- IFN sensitivity and sequence homology: 1
- IFN sensitivity and viral protein: 1, 2, 3, 4
- previous work and SARS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- previous work and SARS viral protein: 1
- previous work and sequence analysis: 1, 2, 3
- previous work and sequence homology: 1
- previous work and viral protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- SARS change and sequence analysis: 1, 2, 3, 4, 5, 6, 7
- SARS change and survey group: 1, 2
- SARS change and viral protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- SARS cov and sequence analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82
- SARS cov and sequence homology: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77
Co phrase search for related documents, hyperlinks ordered by date